SMH
RNTX

Sanders Morris Harris’s Rein Therapeutics RNTX Stock Holding History

Sanders Morris Harris’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,000
Closed -$26K – 295
2026
Q1 		$26K Buy
+20,000
New +$24.8K ﹤0.01% 292

Other funds holding RNTX

SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Sanders Morris Harris's RNTX Position: Q2 2026 in Review

Sanders Morris Harris sold out of Rein Therapeutics (RNTX) in Q2 2026, closing a stake of 20,000 shares — an estimated $26K sold.

Sanders Morris Harris first reported a position in RNTX in Q1 2026 and held it in 1 quarter. The position peaked at $26K in Q1 2026. 5 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

  • Sanders Morris Harris reported no remaining Rein Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Sanders Morris Harris sold 20,000 Rein Therapeutics shares in Q2 2026, an estimated $26K.
  • Sanders Morris Harris first reported a position in Rein Therapeutics in Q1 2026 and held it in 1 quarter.
  • Sanders Morris Harris's Rein Therapeutics position peaked at $26K in Q1 2026.
  • 5 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.